DOCSLIB.ORG

Download (4MB)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download (4MB) Royle, Jamie (2021) Discovery and characterisation of host-factors involved in Zika virus. PhD thesis. http://theses.gla.ac.uk/82306/ Copyright and moral rights for this work are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This work cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Enlighten: Theses https://theses.gla.ac.uk/ [email protected] Discovery and characterisation of host-factors involved in Zika virus infection Jamie Royle, BSc, MBiol Submitted in the fulfilment for the degree of Doctor of Philosophy in Virology. MRC-University of Glasgow Centre for Virus Research Institute of Infection, Immunity and Inflammation College of Medical, Veterinary and Life Sciences University of Glasgow 2 Abstract Zika virus (ZIKV, Flaviviridae), like other emerging arboviruses, poses a considerable threat to human health. It is estimated that approximately half of the world’s population is at risk from contracting a mosquito-borne arboviral infection, and this was exemplified during the 2015/16 ZIKV outbreak in the Americas. ZIKV infection is thought to be largely asymptomatic, although ZIKV disease has previously been characterised by mild symptoms such as a maculopapular rash, conjunctivitis, and fever. However, recent outbreaks have been associated with an increased incidence of Guillain-Barré syndrome, and a pattern of neurological and developmental symptoms in neonates which is now termed congenital Zika syndrome. Despite intense efforts, no therapeutic or vaccine has been developed. As such, it is vital that further fundamental research is conducted to discover novel host-virus interactions in both vector and mammalian host systems, which may allow development of targeted interventions. Here, multiple approaches were used to generate basic tools for ZIKV research, and siRNA screens and data from mass-spectrometry based proteomics were utilised to uncover important host interactors of ZIKV. A study investigating the Aedes aegypti immune response was conducted, and the classical RNAi effector Argonaute 2 (Ago2) was not found to be antiviral, whereas PIWI 4 was. Data from a previous proteomics experiment suggested that glucose-regulated protein 78 kDa (GRP78) may interact with ZIKV E. In this study, co-immunoprecipitation and immunofluorescence was used to verify that GRP78 interacts with ZIKV E in both mammalian and Aedes aegypti cell culture. GRP78 is a key modulator of the unfolded protein response (UPR), and while small-molecule inhibitors (EGCG and HNK) of the GRP78-mediated UPR did not inhibit ZIKV infection, EGCG was able to inhibit ZIKV entry independent of GRP78, likely through direct binding of the virion. Further study of GRP78 revealed that while it is not important for entry, replication, or egress of ZIKV, it did aid viral translation. Depletion of GRP78 with siRNA resulted in a loss of coordination of viral replication factories and relieved 3 a virus-specific inhibition of host translation. Furthermore, STRING analysis of GRP78 host-interactors followed by a targeted siRNA screen revealed that DnaJC1 is also a pro-viral factor. DnaJC1 has previously been shown to coordinate GRP78 localisation to ribosome exit tunnels, and so may contribute to ZIKV infection through GRP78, though this was not assessed in this study. Additionally, by using a circular polymerase extension reaction (CPER) system, a reverse genetics ZIKV was generated. This CPER ZIKV represents a genetically stable source of virus which can be easily modified and can support future research. Collectively, the data herein informs on important ZIKV interactions in both arthropod vector and mammalian systems, and highlights tools and techniques that can be used to conduct future fundamental ZIKV research. 4 Table of Contents Abstract ...................................................................................... 2 List of Tables ................................................................................ 8 List of Figures ............................................................................... 9 Abbreviations .............................................................................. 12 Publications ................................................................................ 15 Acknowledgements ........................................................................ 16 Authors Declaration ....................................................................... 18 Chapter 1. Introduction ................................................................. 19 1.1 Flaviviridae ....................................................................... 19 1.1.1 Taxonomy .................................................................... 19 1.1.2 Flavivirus Genomic RNA .................................................... 22 1.1.3 Flavivirus protein expression ............................................. 25 1.1.4 Virus structure .............................................................. 35 1.1.5 Geographical distribution and vectors ................................... 37 1.1.6 Economic and health burden .............................................. 40 1.1.7 Infection cycle .............................................................. 42 1.2 ZIKV: historical perspective and properties ................................. 45 1.2.1 Discovery and spread ....................................................... 45 1.2.2 Transmission ................................................................. 48 1.2.3 Health implications ......................................................... 52 1.2.4 Replicative cycle ........................................................... 54 1.2.5 Antivirals and vaccine development ..................................... 57 1.2.6 Interactions with the host cell ............................................ 58 1.3 GRP78 ............................................................................. 60 1.3.1 Zika virus E protein may interact with GRP78 .......................... 60 1.3.2 The structure and function of GRP78 .................................... 60 1.3.3 GRP78 and virus lifecycles ................................................ 64 Chapter 2. Aims .......................................................................... 68 Chapter 3. Materials and Methods ..................................................... 69 5 3.1 Materials .......................................................................... 69 3.1.1 Cell culture .................................................................. 69 3.1.2 Cell culture reagents ....................................................... 70 3.1.3 Viruses ........................................................................ 70 3.1.4 Plasmids ...................................................................... 71 3.1.5 Primers ....................................................................... 72 3.1.6 siRNA ......................................................................... 74 3.1.7 Antibodies ................................................................... 75 3.1.8 Commercial kits and general reagents .................................. 76 3.1.9 Buffers ....................................................................... 77 3.1.10 Enzymes ...................................................................... 78 3.1.11 Bacteria ...................................................................... 78 3.2 Methods ........................................................................... 79 3.2.1 Cell culture maintenance ................................................. 79 3.2.2 Cell culture transfection .................................................. 80 3.2.3 Lentivirus production and transduction of cells........................ 81 3.2.4 Virus rescue and amplification ........................................... 82 3.2.5 Circular polymerase extension reaction ................................. 83 3.2.6 Large scale siRNA screen .................................................. 85 3.2.7 Plaque assays ................................................................ 85 3.2.8 Luciferase assays ........................................................... 85 3.2.9 Freeze/thaw assay ......................................................... 86 3.2.10 Western blot analysis ...................................................... 87 3.2.11 Immunofluorescence ....................................................... 87 3.2.12 RNA extraction and RT-qPCR .............................................. 88 3.2.13 dsRNA synthesis ............................................................. 88 3.2.14 Co-Immunoprecipitation ................................................... 89 3.2.15 Mass spectrometry analysis ............................................... 89 3.2.16 Bacterial transformation .................................................. 90 3.2.17 Plasmid purification ........................................................ 91 6 Chapter 4. Investigating Aedes aegypti immune factors that regulate ZIKV infection .................................................................................... 92 4.1 Introduction .....................................................................
Load more

Recommended publications
  • Flavivirus: from Structure to Therapeutics Development
    life Review Flavivirus: From Structure to Therapeutics Development Rong Zhao 1,2,†, Meiyue Wang 1,2,†, Jing Cao 1,2, Jing Shen 1,2, Xin Zhou 3, Deping Wang 1,2,* and Jimin Cao 1,2,* 1 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China; [email protected] (R.Z.); [email protected] (M.W.); [email protected] (J.C.); [email protected] (J.S.) 2 Department of Physiology, Shanxi Medical University, Taiyuan 030001, China 3 Department of Medical Imaging, Shanxi Medical University, Taiyuan 030001, China; [email protected] * Correspondence: [email protected] (D.W.); [email protected] (J.C.) † These authors contributed equally to this work. Abstract: Flaviviruses are still a hidden threat to global human safety, as we are reminded by recent reports of dengue virus infections in Singapore and African-lineage-like Zika virus infections in Brazil. Therapeutic drugs or vaccines for flavivirus infections are in urgent need but are not well developed. The Flaviviridae family comprises a large group of enveloped viruses with a single-strand RNA genome of positive polarity. The genome of flavivirus encodes ten proteins, and each of them plays a different and important role in viral infection. In this review, we briefly summarized the major information of flavivirus and further introduced some strategies for the design and development of vaccines and anti-flavivirus compound drugs based on the structure of the viral proteins. There is no doubt that in the past few years, studies of antiviral drugs have achieved solid progress based on better understanding of the flavivirus biology.
    [Show full text]
  • Supp Material.Pdf
    Simon et al. Supplementary information: Table of contents p.1 Supplementary material and methods p.2-4 • PoIy(I)-poly(C) Treatment • Flow Cytometry and Immunohistochemistry • Western Blotting • Quantitative RT-PCR • Fluorescence In Situ Hybridization • RNA-Seq • Exome capture • Sequencing Supplementary Figures and Tables Suppl. items Description pages Figure 1 Inactivation of Ezh2 affects normal thymocyte development 5 Figure 2 Ezh2 mouse leukemias express cell surface T cell receptor 6 Figure 3 Expression of EZH2 and Hox genes in T-ALL 7 Figure 4 Additional mutation et deletion of chromatin modifiers in T-ALL 8 Figure 5 PRC2 expression and activity in human lymphoproliferative disease 9 Figure 6 PRC2 regulatory network (String analysis) 10 Table 1 Primers and probes for detection of PRC2 genes 11 Table 2 Patient and T-ALL characteristics 12 Table 3 Statistics of RNA and DNA sequencing 13 Table 4 Mutations found in human T-ALLs (see Fig. 3D and Suppl. Fig. 4) 14 Table 5 SNP populations in analyzed human T-ALL samples 15 Table 6 List of altered genes in T-ALL for DAVID analysis 20 Table 7 List of David functional clusters 31 Table 8 List of acquired SNP tested in normal non leukemic DNA 32 1 Simon et al. Supplementary Material and Methods PoIy(I)-poly(C) Treatment. pIpC (GE Healthcare Lifesciences) was dissolved in endotoxin-free D-PBS (Gibco) at a concentration of 2 mg/ml. Mice received four consecutive injections of 150 μg pIpC every other day. The day of the last pIpC injection was designated as day 0 of experiment.
    [Show full text]
  • The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley
    The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley William Michael Cook A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Master of Science Department of Microbiology University of Manitoba Winnipeg, Manitoba, Canada Copyright © 2010 by Bradley William Michael Cook 1 List of Abbreviations: AHFV - Alkhurma Hemorrhagic Fever Virus Amp – ampicillin APOIV - Apoi Virus ATP – adenosine tri-phosphate BAC – bacterial artificial chromosome BHK – Baby Hamster Kidney BSA – bovine serum albumin C1 – C-terminus fragment 1 C2 – C-terminus fragment 2 C - Capsid protein cDNA – comlementary Deoxyribonucleic acid CL – Containment Level CO2 – carbon dioxide cHP - capsid hairpin CNS - Central Nervous System CPE – cytopathic effect CS - complementary sequences DENV1-4 - Dengue Virus DIC - Disseminated Intravascular Coagulation (DIC) DNA – Deoxyribonucleic acid DTV - Deer Tick Virus 2 E - Envelope protein EDTA - ethylenediaminetetraacetic acid EM - Electron Microscopy EMCV – Encephalomyocarditis Virus ER - endoplasmic reticulum FBS – fetal bovine serum FP - fusion peptide GGEV - Greek Goat Encephalitis Virus GGYV - Gadgets Gully Virus GMP - Guanosine mono-phosphate GTP - Guanosine tri-phosphate HBV- Hepatitis B Virus HDV – Hepatitis Delta Virus HIV - Human Immunodeficiency Virus IFN – interferon IRES – internal ribosome entry sequence JEV - Japanese Encephalitis Virus KADV - Kadam Virus kDa -
    [Show full text]
  • Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives Ashok Munjal
    Old Dominion University ODU Digital Commons Bioelectrics Publications Frank Reidy Research Center for Bioelectrics 8-2017 Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives Ashok Munjal Rekha Khandia Kuldeep Dharma Swati Sachan Kumaragurubaran Karthik See next page for additional authors Follow this and additional works at: https://digitalcommons.odu.edu/bioelectrics_pubs Part of the Public Health Commons, Virology Commons, and the Virus Diseases Commons Repository Citation Munjal, Ashok; Khandia, Rekha; Dharma, Kuldeep; Sachan, Swati; Karthik, Kumaragurubaran; Tiwari, Ruchi; Malik, Yashpal S.; Kumar, Deepak; Singh, Raj K.; Iqbal, Hafiz M. N.; and Joshi, Sunil K., "Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives" (2017). Bioelectrics Publications. 132. https://digitalcommons.odu.edu/bioelectrics_pubs/132 Original Publication Citation Munjal, A., Khandia, R., Dhama, K., Sachan, S., Karthik, K., Tiwari, R., . Joshi, S. K. (2017). Advances in developing therapies to combat zika virus: Current knowledge and future perspectives. Frontiers in Microbiology, 8, 1469. doi:10.3389/fmicb.2017.01469 This Article is brought to you for free and open access by the Frank Reidy Research Center for Bioelectrics at ODU Digital Commons. It has been accepted for inclusion in Bioelectrics Publications by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. Authors Ashok Munjal, Rekha Khandia, Kuldeep Dharma,
    [Show full text]
  • Exploratory Re-Encoding of Yellow Fever Virus Genome: New In- Sights for the Design of Live-Attenuated Viruses
    bioRxiv preprint doi: https://doi.org/10.1101/256610; this version posted May 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Exploratory re-encoding of Yellow Fever Virus genome: new in- sights for the design of live-attenuated viruses Short title: Exploratory re-encoding of Yellow Fever Virus genome R. Klitting1*, T. Riziki1, G. Moureau1, G. Piorkowski1, E. A. Gould1, X. de Lamballerie1 1Unité des Virus Émergents (UVE: Aix-Marseille Univ – IRD 190 – Inserm 1207 – IHU Méditerranée Infection), Marseille, France *Corresponding Author E-mail: [email protected] (RK) bioRxiv preprint doi: https://doi.org/10.1101/256610; this version posted May 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Virus attenuation by genome re-encoding is a pioneering approach for generating effective live-attenuated vaccine candidates. Its core principle is to introduce a large number of synonymous substitutions into the viral genome to produce stable attenuation of the targeted virus. Introduction of large numbers of mutations has also been shown to maintain stability of the attenuated phenotype by lowering the risk of reversion and recombination of re-encoded genomes. Identifying mutations with low fitness cost is pivotal as this increases the number that can be introduced and generates more stable and attenuated viruses. Here, we sought to identify mutations with low deleterious impact on the in vivo replication and virulence of yellow fever virus (YFV).
    [Show full text]
  • Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence
    crossmark Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence Alexander J. McAuley,a,b Maricela Torres,a Jessica A. Plante,b,c* Claire Y.-H. Huang,d Dennis A. Bente,a,b,e,f David W. C. Beasleya,b,e,f Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USAa; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USAb; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USAc; Arbovirus Diseases Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Fort Collins, Colorado, USAd; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, USAe; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, USAf ABSTRACT Flaviviruses are positive-sense, single-stranded RNA viruses responsible for millions of human infections annually. The enve- lope (E) protein of flaviviruses comprises three structural domains, of which domain III (EIII) represents a discrete subunit. The EIII gene sequence typically encodes epitopes recognized by virus-specific, potently neutralizing antibodies, and EIII is believed to play a major role in receptor binding. In order to assess potential interactions between EIII and the remainder of the E protein and to assess the effects of EIII sequence substitutions on the antigenicity, growth, and virulence of a representative flavivirus, chimeric viruses were generated using the West Nile virus (WNV) infectious clone, into which EIIIs from nine flaviviruses with various levels of genetic diversity from WNV were substituted.
    [Show full text]
  • Generation of a Lineage II Powassan Virus (Deer Tick Virus) Cdna Clone: Assessment of Flaviviral Genetic Determinants of Tick and Mosquito Vector Competence
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Vector Borne Manuscript Author Zoonotic Dis Manuscript Author . Author manuscript; available in PMC 2019 July 01. Published in final edited form as: Vector Borne Zoonotic Dis. 2018 July ; 18(7): 371–381. doi:10.1089/vbz.2017.2224. Generation of a Lineage II Powassan Virus (Deer Tick Virus) cDNA Clone: Assessment of Flaviviral Genetic Determinants of Tick and Mosquito Vector Competence Joan L. Kenney1, Michael Anishchenko1, Meghan Hermance2, Hannah Romo1, Ching-I Chen3, Saravanan Thangamani2, and Aaron C. Brault1 1Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 2Department of Pathology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas 3Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, California Abstract The Flavivirus genus comprises a diverse group of viruses that utilize a wide range of vertebrate hosts and arthropod vectors. The genus includes viruses that are transmitted solely by mosquitoes or vertebrate hosts as well as viruses that alternate transmission between mosquitoes or ticks and vertebrates. Nevertheless, the viral genetic determinants that dictate these unique flaviviral host and vector specificities have been poorly characterized. In this report, a cDNA clone of a flavivirus that is transmitted between ticks and vertebrates (Powassan lineage II, deer tick virus [DTV]) was generated and chimeric viruses between the mosquito/vertebrate flavivirus, West Nile virus (WNV), were constructed. These chimeric viruses expressed the prM and E genes of either WNV or DTV in the heterologous nonstructural (NS) backbone. Recombinant chimeric viruses rescued from cDNAs were characterized for their capacity to grow in vertebrate and arthropod (mosquito and tick) cells as well as for in vivo vector competence in mosquitoes and ticks.
    [Show full text]
  • Flaviviridae; Flavivirus) in Persistently Infected Hamsters
    Am. J. Trop. Med. Hyg., 88(3), 2013, pp. 455–460 doi:10.4269/ajtmh.12-0110 Copyright © 2013 by The American Society of Tropical Medicine and Hygiene Pathogenesis of Modoc Virus (Flaviviridae; Flavivirus) in Persistently Infected Hamsters A. Paige Adams,* Amelia P. A. Travassos da Rosa, Marcio R. Nunes, Shu-Yuan Xiao, and Robert B. Tesh Center for Biodefense and Emerging Infectious Diseases and Department of Pathology, University of Texas Medical Branch, Galveston, Texas Abstract. The long-term persistence of Modoc virus (MODV) infection was investigated in a hamster model. Golden hamsters (Mesocricetus auratus) were infected by subcutaneous inoculation with MODV, in which fatal encephalitis developed in 12.5% (2 of 16). Surviving hamsters shed infectious MODV in their urine during the first five months after infection, and infectious MODV was recovered by co-cultivation of kidney tissue up to eight months after infection. There were no histopathologic changes observed in the kidneys despite detection of viral antigen for 250 days after infection. Mild inflammation and neuronal degeneration in the central nervous system were the primary lesions observed during early infection. These findings confirm previous reports of persistent flavivirus infection in animals and suggest a mechanism for the maintenance of MODV in nature. INTRODUCTION Recent reports of chronic infection with a number of differ- – ent flaviviruses7 11 has renewed interest in the subject of Modoc virus (MODV) is a rodent-associated flavivirus that persistent flavivirus infection and the role it might play in has no known arthropod vector. Taxonomically, it is included virus maintenance and pathogenesis in the vertebrate host.
    [Show full text]
  • Yellow Fever in a Traveller Returning from Suriname to the Netherlands, March 2017
    Rapid communications Yellow fever in a traveller returning from Suriname to the Netherlands, March 2017 M Wouthuyzen-Bakker 1 2 , M Knoester 2 3 , AP van den Berg ⁴ , CH GeurtsvanKessel ⁵ , MP Koopmans ⁵ , C Van Leer-Buter ³ , B Oude Velthuis ⁶ , SD Pas ⁵ , WL Ruijs ⁷ , J Schmidt-Chanasit 8 9 , SG Vreden 10 , TS van der Werf ¹ , CB Reusken ⁵ , WF Bierman ¹ 1. University of Groningen, University Medical Center Groningen, Department of Internal Medicine / Infectious Diseases, Groningen, The Netherlands 2. These authors contributed equally to this work 3. University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands 4. University of Groningen, University Medical Center Groningen, Department of Gastroenterology & Hepatology, Groningen, The Netherlands 5. Erasmus MC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Rotterdam, The Netherlands 6. University of Groningen, University Medical Center Groningen, Department of Critical Care, Groningen, The Netherlands 7. National Coordination Centre for Communicable Disease Control, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands 8. Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Hamburg, Germany 9. German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany 10. Academic Hospital Paramaribo, Department of Internal Medicine and Infectious Diseases, Paramaribo, Suriname Correspondence: Wouter FW Bierman ([email protected]) Citation style for this article: Wouthuyzen-Bakker M, Knoester M, van den Berg AP, GeurtsvanKessel CH, Koopmans MP, Van Leer-Buter C, Oude Velthuis B, Pas SD, Ruijs WL, Schmidt-Chanasit J, Vreden SG, van der Werf TS, Reusken CB, Bierman WF.
    [Show full text]
  • Flavivirus Infectious Clones Issue Date: 2013-11-06 Construction, Characterization and Application of Flavivirus Infectious Clones
    Cover Page The handle http://hdl.handle.net/1887/22114 holds various files of this Leiden University dissertation Author: Jiang, Xiaohong Title: Construction characterization and application of Flavivirus infectious clones Issue Date: 2013-11-06 Construction, Characterization and Application of Flavivirus Infectious Clones Xiaohong Jiang ISBN: 978-90-8891-733-2 Cover design: Xiaohong Jiang, Joe Zhou and Kerry Zhang (K&A Inc.) The image on the front cover is a schematic representation of the landmarks in Shanghai, China, which is sketched out by the use of predicted RNA structural elements in the 3’-UTR of flaviviruses as illustrated in the thesis. Layout and printing: Proefschriftmaken.nl || Uitgeverij BOXPress Published by: Uitgeverij BOXPress, ’s-Hertogenbosch Construction, Characterization and Application of Flavivirus Infectious Clones Proefschrift ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof. mr. C.J.J.M. Stolker, volgens besluit van het College voor Promoties te verdedigen op woensdag 6 november 2013 klokke 11:15 uur door Xiaohong Jiang geboren te Shanghai, China in 1983 PROMOTIECOMMISSIE Promotor: Prof. Dr. W.J.M. Spaan Copromotor: Dr. P.J. Bredenbeek Overige leden: Prof. Dr. E.J. Snijder Prof. Dr. R.C. Hoeben Dr. D. Franco (Katholieke Universiteit Leuven) Prof. Dr. J.H. Neyts (Katholieke Universiteit Leuven) 献给我挚爱的父母 5 6 CONTENTS Chapter 1 General Introduction 9 Chapter 2 Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection
    [Show full text]
  • A Novel Model for the Study of the Therapy of Flavivirus Infections Using the Modoc Virus
    Virology 279, 27–37 (2001) doi:10.1006/viro.2000.0723, available online at http://www.idealibrary.com on CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector A Novel Model for the Study of the Therapy of Flavivirus Infections Using the Modoc Virus Pieter Leyssen,* Alfons Van Lommel,† Christian Drosten,‡ Herbert Schmitz,‡ Erik De Clercq,* and Johan Neyts*,1 *Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven B-3000, Belgium; †Division of Histopathology, University Hospitals, Leuven B-3000, Belgium; and ‡Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany Received May 31, 2000; returned to author for revision July 21, 2000; accepted October 26, 2000 The murine Flavivirus Modoc replicates well in Vero cells and appears to be as equally sensitive as both yellow fever and dengue fever virus to a selection of antiviral agents. Infection of SCID mice, by either the intracerebral, intraperitoneal, or intranasal route, results in 100% mortality. Immunocompetent mice and hamsters proved to be susceptible to the virus only when inoculated via the intranasal or intracerebral route. Animals ultimately die of (histologically proven) encephalitis with features similar to Flavivirus encephalitis in man. Viral RNA was detected in the brain, spleen, and salivary glands of infected SCID mice and the brain, lung, kidney, and salivary glands of infected hamsters. In SCID mice, the interferon inducer poly IC protected against Modoc virus-induced morbidity and mortality and this protection was associated with a reduction in infectious virus content and viral RNA load. Infected hamsters shed the virus in the urine. This allows daily monitoring of (inhibition of) viral replication, by means of a noninvasive method and in the same animal.
    [Show full text]
  • Dynamic Patterns of Histone Methylation Are Associated With
    Molecular Pharmacology Fast Forward. Published on February 2, 2009 as doi:10.1124/mol.108.052993 MOL #52993 Dynamic Patterns of Histone Methylation are Associated with Ontogenic Expression of the Cyp3a Genes during Mouse Liver Maturation Ye Li, Yue Cui, Steven N. Hart, Curtis D. Klaassen, and Xiao-bo Zhong Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, USA. 1 Copyright 2009 by the American Society for Pharmacology and Experimental Therapeutics. MOL #52993 Running title: Epigenetic control of Cyp3a expression in liver maturation Corresponding author: Dr. Xiao-bo Zhong, Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, USA. Telephone: 913-588-0401; Fax: 913-588-7501; E- mail: [email protected]. Number of text pages: 28 Number of tables: 1 Number of figures: 5 Number of references: 40 Number of words in Abstract: 243 Number of words in Introduction: 736 Number of words in Discussion: 1316 Abbreviations: CYP3A4: human cytochrome P450, family 3, subfamily A, polypeptide 4 gene; CYP3A7: human cytochrome P450, family 3, subfamily A, polypeptide 7 gene; Cyp3a11: mouse cytochrome P450, family 3, subfamily a, polypeptide 11 gene; Cyp3a16: mouse cytochrome P450, family 3, subfamily a, polypeptide 16 gene; DNAme: DNA methylation; H3K4me2: histone 3 lysine 4 dimethylation; H3K27me3: histone 3 lysine 27 trimethylation. 2 MOL #52993 Abstract Human cytochrome P450 3A members (CYP3As) are major drug-metabolizing enzymes in livers. Two genes, CYP3A4 and CYP3A7, exhibit a developmental switch in gene expression during liver maturation.
    [Show full text]